Parosmia adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 7,405 adverse event reports that record the MedDRA preferred term Parosmia. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 410 reports in the 12 months to June 2026 and 421 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,091 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 410 (under 0.1%) record this term. Reports for patients aged 45 to 64 were 30.8% of the reports that record this term and 20% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 118 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Parosmia name as a suspect product, in order of name
Drug	Class	Reports with this term
Acetaminophen		117
Adalimumab	Tumor necrosis factor blocker	142
Albendazole		113
Aminosalicylic Acid		28
Amitriptyline		52
Asacol		138
Aspirin	Nonsteroidal anti-inflammatory drug	153
Astrazeneca Covid-19 Vaccine		48
Ayvakit	Kinase inhibitor	25
Budesonide	Corticosteroid	155
Bupropion hydrochloride	Aminoketone	26
Byetta	GLP-1 receptor agonist	54
Cabometyx	Kinase inhibitor	37
Candesartan	Angiotensin 2 receptor blocker	129
Candesartan cilexetil	Angiotensin 2 receptor blocker	35
Chantix	Partial cholinergic nicotinic agonist	217
Cholecalciferol		99
Ciprofloxacin	Fluoroquinolone antibacterial	46
Clarithromycin	Macrolide antimicrobial	31
Clonazepam	Benzodiazepine	80
Codeine		36
Codeine phosphate		27
Comirnaty		108
Cortifoam	Corticosteroid	130
Cortisone	Corticosteroid	83
Cosentyx	Interleukin-17A antagonist	48
Crestor	HMG-CoA reductase inhibitor	59
Cyclophosphamide	Alkylating drug	34
Cymbalta		69
Dapagliflozin	Sodium-Glucose cotransporter 2 inhibitor	145
Desoximetasone	Corticosteroid	89
Diazepam	Benzodiazepine	68
Domperidone		67
Dupixent	Interleukin-4 receptor alpha antagonist	276
Enbrel	Tumor necrosis factor blocker	80
Entyvio	Integrin receptor antagonist	143
Epinephrine	Catecholamine	74
Epinephrine hydrochloride	Catecholamine	68
Ergocalciferol	Provitamin D2 compound	94
Esbriet	Pyridone	36
Escitalopram	Serotonin reuptake inhibitor	138
Escitalopram oxalate	Serotonin reuptake inhibitor	27
Esomeprazole	Proton pump inhibitor	137
Felodipine	Dihydropyridine calcium channel blocker	144
Flonase	Corticosteroid	73
Forteo	Parathyroid hormone analog	38
Fulvestrant	Estrogen receptor antagonist	25
Furosemide	Loop diuretic	150
Gabapentin	Anti-epileptic agent	169
Humira		234
Hydrocortisone	Corticosteroid	141
Hydrocortisone acetate	Corticosteroid	57
Ibrance	Kinase inhibitor	76
Imbruvica	Kinase inhibitor	25
Incivek		40
Inflectra	Tumor necrosis factor blocker	57
Infliximab	Tumor necrosis factor blocker	152
Kisqali	Kinase inhibitor	29
Levofloxacin	Fluoroquinolone antibacterial	32
Levothyroxine		70
Levothyroxine sodium	l-Thyroxine	100
Lisdexamfetamine dimesylate	Central nervous system stimulant	94
Lorazepam	Benzodiazepine	81
Lyrica		39
Mebeverine		60
Mesalamine	Aminosalicylate	159
Metformin	Biguanide	168
Methotrexate	Folate analog metabolic inhibitor	50
Metronidazole	Nitroimidazole antimicrobial	47
Mirena	Progestin	39
Mirtazapine		73
Mounjaro	GLP-1 receptor agonist	36
Ocrevus	CD20-directed cytolytic antibody	26
Ofev	Kinase inhibitor	27
Omeprazole	Proton pump inhibitor	225
Otezla	Phosphodiesterase 4 inhibitor	40
Oxycodone	Opioid agonist	108
Oxycodone hydrochloride	Opioid agonist	49
Ozempic	GLP-1 receptor agonist	60
Pantoprazole	Proton pump inhibitor	42
Para-Aminosalicylic Acid		93
Paroxetine	Serotonin reuptake inhibitor	51
Paroxetine hydrochloride	Serotonin reuptake inhibitor	53
Paxlovid		83
Peg-Intron		34
Pegasys	Interferon alpha	53
Phosphorus		48
Prednisone	Corticosteroid	196
Procyclidine		42
Pulmicort Turbuhaler		33
Quetiapine	Atypical antipsychotic	44
Quetiapine fumarate	Atypical antipsychotic	27
Ramipril	Angiotensin converting enzyme inhibitor	47
Remicade	Tumor necrosis factor blocker	56
Repatha	PCSK9 inhibitor	26
Revlimid	Thalidomide analog	106
Ribavirin	Nucleoside analog antiviral	77
Rosuvastatin	HMG-CoA reductase inhibitor	132
Rosuvastatin calcium	HMG-CoA reductase inhibitor	25
Rubraca	Poly(ADP-Ribose) polymerase inhibitor	25
Sulfasalazine	Aminosalicylate	147
Symbicort	Corticosteroid	31
Tecfidera		47
Tiotropium bromide	Anticholinergic	28
Topiramate		26
Tozinameran		74
Tramadol		51
Tramadol hydrochloride	Opioid agonist	33
Trulicity	GLP-1 receptor agonist	40
Tysabri	Integrin receptor antagonist	39
Vedolizumab	Integrin receptor antagonist	95
Vyvanse	Central nervous system stimulant	74
Warfarin	Vitamin K antagonist	135
Warfarin sodium	Vitamin K antagonist	119
Xolair	Anti-IgE	33
Zejula	Poly(ADP-Ribose) polymerase inhibitor	25
Zepbound	GLP-1 receptor agonist	28
Zicam	Non-Standardized food allergenic extract	34

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 40 pharmacologic classes with 50 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Parosmia name, in order of name
Class	Reports with this term
Aminoketone	50
Aminosalicylate	308
Angiotensin 2 receptor blocker	182
Angiotensin converting enzyme inhibitor	57
Anti-epileptic agent	214
Atypical antipsychotic	128
Benzodiazepine	258
Biguanide	181
Catecholamine	74
CD20-directed cytolytic antibody	50
Central nervous system stimulant	195
Corticosteroid	1,021
Dihydropyridine calcium channel blocker	146
Fluoroquinolone antibacterial	82
Folate analog metabolic inhibitor	57
GLP-1 receptor agonist	258
Histamine-1 receptor antagonist	53
HMG-CoA reductase inhibitor	250
Integrin receptor antagonist	277
Interferon alpha	53
Interleukin-17A antagonist	51
Interleukin-4 receptor alpha antagonist	285
Kinase inhibitor	353
l-Thyroxine	109
Loop diuretic	172
Macrolide antimicrobial	52
Nonsteroidal anti-inflammatory drug	205
Nucleoside analog antiviral	80
Opioid agonist	243
Partial cholinergic nicotinic agonist	220
Poly(ADP-Ribose) polymerase inhibitor	63
Progestin	64
Proton pump inhibitor	484
Provitamin D2 compound	104
Serotonin and norepinephrine reuptake inhibitor	58
Serotonin reuptake inhibitor	337
Sodium-Glucose cotransporter 2 inhibitor	155
Thalidomide analog	116
Tumor necrosis factor blocker	507
Vitamin K antagonist	254

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Parosmia, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Parosmia
Age	Reports	Share
Under 2	4	0.1%
2 to 11	16	0.2%
12 to 17	48	0.6%
18 to 44	1,146	15.5%
45 to 64	2,279	30.8%
65 to 74	863	11.7%
75 and over	402	5.4%
Age not given	2,647	35.7%

Sex of the patient in the reports that record Parosmia
Sex	Reports	Share
Female	4,577	61.8%
Male	2,232	30.1%
Unknown or not given	596	8%

Age and sex are as the report gives them. 69.4% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Parosmia: adverse event reports that record this term. https://reportedreactions.com/reaction/parosmia/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Parosmia mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page